SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

FRA:1SXP Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 20, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	2,298	3,178	4,618	4,765	-	-
Market Cap Growth	-35.83%	-31.18%	-3.10%	-	-	-
Enterprise Value	2,623	3,440	4,867	4,914	-	-
Last Close Price	15.20	20.88	30.60	30.87	-	-
PE Ratio	15.33	21.70	30.85	31.38	-	-
PS Ratio	2.31	3.22	4.83	5.30	-	-
PB Ratio	2.47	3.56	5.86	6.89	-	-
P/TBV Ratio	2.55	3.69	6.11	7.23	-	-
P/FCF Ratio	198.24	89.28	57.95	770.48	-	-
P/OCF Ratio	14.52	17.66	20.55	26.23	-	-
EV/Sales Ratio	2.64	3.49	5.09	5.47	-	-
EV/EBITDA Ratio	9.18	13.25	19.55	22.59	-	-
EV/EBIT Ratio	12.90	18.52	25.77	28.70	-	-
EV/FCF Ratio	226.23	96.63	61.07	794.52	-	-
Debt / Equity Ratio	0.37	0.34	0.36	0.30	0.28	0.24
Debt / EBITDA Ratio	1.28	1.14	1.13	0.94	0.92	0.67
Debt / FCF Ratio	29.93	8.51	3.59	33.92	6.49	2.95
Net Debt / Equity Ratio	0.35	0.31	0.33	0.27	0.23	0.17
Net Debt / EBITDA Ratio	1.22	1.07	1.04	0.85	0.78	0.48
Net Debt / FCF Ratio	27.80	7.79	3.26	29.74	5.48	2.13
Asset Turnover	0.64	0.65	0.72	0.74	0.85	0.97
Inventory Turnover	3.94	4.07	4.45	4.35	4.94	5.76
Quick Ratio	0.70	0.75	0.66	0.80	0.80	0.80
Current Ratio	1.58	1.50	1.34	1.33	1.72	1.24
Return on Equity (ROE)	17.06%	17.47%	20.31%	21.69%	22.30%	27.53%
Return on Assets (ROA)	7.57%	7.65%	8.84%	8.81%	10.85%	10.71%
Return on Invested Capital (ROIC)	12.09%	13.10%	16.04%	16.00%	19.55%	21.34%
Return on Capital Employed (ROCE)	15.90%	16.20%	18.80%	19.40%	19.20%	23.10%
Earnings Yield	6.52%	4.61%	3.24%	3.19%	-	-
FCF Yield	0.50%	1.12%	1.73%	0.13%	-	-
Dividend Yield	1.20%	0.86%	0.52%	0.49%	-	-
Payout Ratio	16.07%	16.45%	15.09%	12.43%	9.14%	39.53%
Buyback Yield / Dilution	-1.18%	-	-	-	0.00%	-
Total Shareholder Return	0.01%	0.86%	0.52%	0.49%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.